It can lead to the G0/G1 phase arrest by regulating the cell cycle of the human lung cancer cells, and affect the expression of CDK2 to further regulate the proliferation of the lung cancer cells, providing a new potential therapeutic target for the treatment of cancer (70). This evidence concerns the gene CDK2 and lung carcinoma.